Increased β‐site APP cleaving enzyme 1‐mediated insulin receptor cleavage in type 2 diabetes mellitus with cognitive impairment
- 7 January 2021
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 17 (7), 1097-1108
- https://doi.org/10.1002/alz.12276
Abstract
Introduction Patients with type 2 diabetes mellitus (T2DM) are at a high risk of cognitive impairment, with insulin resistance playing a pivotal role. β‐site amyloid precursor protein cleaving enzyme 1 (BACE1) is considered a predictor of Alzheimer's disease. However, the potential roles of BACE1 in insulin resistance and the risk of cognitive impairment in T2DM remain unclear. Methods We measured plasma BACE1 levels, BACE1 cleavage activities for Swedish mutant amyloid precursor protein (APPsw) and insulin receptor β subunit (INSR‐β), and soluble INSR (sINSR) levels in a clinical cohort study. Results T2DM patients with or without cognitive impairment exhibited elevated plasma BACE1 levels and BACE1 enzymatic activities for APPsw and INSR‐β, and sINSR levels. Moreover, the glycemic status correlated with elevated BACE1 levels and BACE1‐mediated INSR cleavage, which was associated with insulin resistance. Discussion The elevated BACE1 levels in T2DM may contribute to increasing the cognitive impairment risk through both amyloidogenesis and insulin resistance.Funding Information
- Chinese Academy of Sciences (QYZDY‐SSW‐SMC012, XDB39000000)
This publication has 47 references indexed in Scilit:
- HbA1c and Risk of Severe Hypoglycemia in Type 2 DiabetesDiabetes Care, 2013
- An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomersJCI Insight, 2012
- The contribution of activated astrocytes to Aβ production: Implications for Alzheimer's disease pathogenesisJournal of Neuroinflammation, 2011
- Cognitive function, dementia and type 2 diabetes mellitus in the elderlyNature Reviews Endocrinology, 2011
- Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 DiabetesArchives of Neurology, 2011
- The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic PotentialJournal of Neuroscience, 2009
- Levels of β-Secretase (BACE1) in Cerebrospinal Fluid as a Predictor of Risk in Mild Cognitive ImpairmentArchives of General Psychiatry, 2007
- Transcriptional and translational regulation of BACE1 expression—Implications for Alzheimer's diseaseProgress in Neurobiology, 2006
- Insulin Resistance in Cognitive ImpairmentArchives of Neurology, 2005
- ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGINGAnnual Review of Medicine, 1995